Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactyferrin is a brand of nutritional supplements and dermocosmetic products developed by the Spanish company Sesderma, primarily featuring lactoferrin as its active ingredient. Lactoferrin is a multifunctional iron-binding glycoprotein belonging to the transferrin family, known for its antimicrobial, antioxidant, and immunomodulatory properties. The Sesderma formulation utilizes liposomal technology, which involves encapsulating the protein in phospholipid vesicles to enhance its stability against gastric degradation and improve systemic bioavailability. In a clinical context, Lactyferrin has been investigated for its potential to boost the innate immune response and provide antiviral protection, notably in the management of non-hospitalized patients with COVID-19.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lactyferrin.